Genetic and epigenetic characteristics of human multiple hepatocellular carcinoma

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Taniguchi, Kazuya ^a   Yamada, Terumasa ^a   Sasaki, Yo ^a   Kato, Kikuya ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; GENOMIC DNA; K RAS PROTEIN; PROTEIN CTNNB1; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER TISSUE; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH RESOLUTION MELTING; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SOMATIC MUTATION; TUMOR GENE; TUMOR SUPPRESSOR GENE; BIOLOGICAL MODEL; DNA MICROARRAY; GENETIC EPIGENESIS; GENETICS; LIVER TUMOR; METASTASIS; MUTATION;

CARCINOMA, HEPATOCELLULAR; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; MODELS, GENETIC; MUTATION; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC;

EID: 77957307009     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-530     Document Type: Article

References (32)

1. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H, Watanabe G, Tsurumaru M. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993, 71(1):19-25. 10.1002/1097-0142(19930101)71:1<19::AID-CNCR2820710105>3.0.CO;2-I, 8380116.
2. Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Sone Y, Toyoda H, Shimada S, Takahashi M, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology (Baltimore, Md) 1997, 25(1):87-92.
3. Nagasue N, Uchida M, Makino Y, Takemoto Y, Yamanoi A, Hayashi T, Chang YC, Kohno H, Nakamura T, Yukaya H. Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 1993, 105(2):488-494.
4. Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, Shirabe K, Nishizaki T, Yanaga K, Sugimachi K. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 1996, 111(3):720-726. 10.1053/gast.1996.v111.pm8780578, 8780578.
5. Japan LCSGo The general rules for the clinical and pathological study of primary liver cancer. 1992, 20-26. Japan LCSGo.
6. Takenaka K, Adachi E, Nishizaki T, Hiroshige K, Ikeda T, Tsuneyoshi M, Sugimachi K. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology (Baltimore, Md) 1994, 19(4):889-894.
7. Okusaka T, Okada S, Nose H, Ishii H, Nakasuka H, Nakayama H, Nagahama H, Yoshimori M, Shimada K, Yamamoto J, et al. The prognosis of patients with hepatocellular carcinoma of multicentric origin. Hepato-gastroenterology 1996, 43(10):919-925.
8. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nature genetics 2002, 31(4):339-346. 10.1038/ng0802-339, 12149612.
9. Buendia MA. Genetics of hepatocellular carcinoma. Seminars in cancer biology 2000, 10(3):185-200. 10.1006/scbi.2000.0319, 10936068.
10. Kawai H, Suda T, Aoyagi Y, Isokawa O, Mita Y, Waguri N, Kuroiwa T, Igarashi M, Tsukada K, Mori S, et al. Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error. Hepatology (Baltimore, Md) 2000, 31(6):1246-1250.
11. Kondo Y, Kanai Y, Sakamoto M, Mizokami M, Ueda R, Hirohashi S. Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis--A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology (Baltimore, Md) 2000, 32(5):970-979.
12. Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, LeBlanc AC, Donovan DJ, Thung SN, Sole M, et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer research 2008, 68(16):6779-6788. 10.1158/0008-5472.CAN-08-0742, 2587454, 18701503.
13. Midorikawa Y, Yamamoto S, Ishikawa S, Kamimura N, Igarashi H, Sugimura H, Makuuchi M, Aburatani H. Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays. Oncogene 2006, 25(40):5581-5590. 10.1038/sj.onc.1209537, 16785998.
14. Patil MA, Gutgemann I, Zhang J, Ho C, Cheung ST, Ginzinger D, Li R, Dykema KJ, So S, Fan ST, et al. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 2005, 26(12):2050-2057. 10.1093/carcin/bgi178, 16000397.
15. Shen L, Ahuja N, Shen Y, Habib NA, Toyota M, Rashid A, Issa JP. DNA methylation and environmental exposures in human hepatocellular carcinoma. Journal of the National Cancer Institute 2002, 94(10):755-761.
16. Lehmann U, Wingen LU, Brakensiek K, Wedemeyer H, Becker T, Heim A, Metzig K, Hasemeier B, Kreipe H, Flemming P. Epigenetic defects of hepatocellular carcinoma are already found in non-neoplastic liver cells from patients with hereditary haemochromatosis. Human molecular genetics 2007, 16(11):1335-1342. 10.1093/hmg/ddm082, 17412760.
17. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer research 1992, 52(13):3674-3678.
18. Yamamoto T, Kajino K, Kudo M, Sasaki Y, Arakawa Y, Hino O. Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA. Hepatology (Baltimore, Md) 1999, 29(5):1446-1452.
19. Chen YJ, Yeh SH, Chen JT, Wu CC, Hsu MT, Tsai SF, Chen PJ, Lin CH. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 2000, 119(2):431-440. 10.1053/gast.2000.9373, 10930378.
20. Morimoto O, Nagano H, Sakon M, Fujiwara Y, Yamada T, Nakagawa H, Miyamoto A, Kondo M, Arai I, Yamamoto T, et al. Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. Journal of hepatology 2003, 39(2):215-221. 10.1016/S0168-8278(03)00233-2, 12873818.
21. Ng IO, Guan XY, Poon RT, Fan ST, Lee JM. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. The Journal of pathology 2003, 199(3):345-353. 10.1002/path.1287, 12579536.
22. Tsuda H, Oda T, Sakamoto M, Hirohashi S. Different pattern of chromosomal allele loss in multiple hepatocellular carcinomas as evidence of their multifocal origin. Cancer research 1992, 52(6):1504-1509.
23. Nomoto S, Kinoshita T, Kato K, Otani S, Kasuya H, Takeda S, Kanazumi N, Sugimoto H, Nakao A. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. British journal of cancer 2007, 97(9):1260-1265. 10.1038/sj.bjc.6604016, 2360457, 17968429.
24. Reed GH, Wittwer CT. Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clinical chemistry 2004, 50(10):1748-1754. 10.1373/clinchem.2003.029751, 15308590.
25. Barrett MT, Scheffer A, Ben-Dor A, Sampas N, Lipson D, Kincaid R, Tsang P, Curry B, Baird K, Meltzer PS, et al. Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. Proceedings of the National Academy of Sciences of the United States of America 2004, 101(51):17765-17770. 10.1073/pnas.0407979101, 535426, 15591353.
26. Jeronimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG, Sidransky D. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. Journal of the National Cancer Institute 2001, 93(22):1747-1752. 10.1093/jnci/93.22.1747, 11717336.
27. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proceedings of the National Academy of Sciences of the United States of America 1996, 93(18):9821-9826. 10.1073/pnas.93.18.9821, 38513, 8790415.
28. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, Faasse MA, Kang GH, Widschwendter M, Weener D, Buchanan D, et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nature genetics 2006, 38(7):787-793. 10.1038/ng1834, 16804544.
29. Pontisso P, Belluco C, Bertorelle R, De Moliner L, Chieco-Bianchi L, Nitti D, Lise M, Alberti A. Hepatitis C virus infection associated with human hepatocellular carcinoma: lack of correlation with p53 abnormalities in Caucasian patients. Cancer 1998, 83(8):1489-1494. 10.1002/(SICI)1097-0142(19981015)83:8<1489::AID-CNCR3>3.0.CO;2-Q, 9781942.
30. Shieh YS, Nguyen C, Vocal MV, Chu HW. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma. Int J Cancer 1993, 54(4):558-562. 10.1002/ijc.2910540407, 8390407, 8390407.
31. Jones S, Chen WD, Parmigiani G, Diehl F, Beerenwinkel N, Antal T, Traulsen A, Nowak MA, Siegel C, Velculescu VE, et al. Comparative lesion sequencing provides insights into tumor evolution. Proceedings of the National Academy of Sciences of the United States of America 2008, 105(11):4283-4288. 10.1073/pnas.0712345105, 2393770, 18337506.
32. Kato K. Impact of the next generation DNA sequencers. International journal of clinical and experimental medicine 2009, 2(2):193-202. 2719707, 19684890.